MAPS & More West MI: Update for Opioid Prescribers
The opioid epidemic has undoubtedly touched every Family Medicine practice in Michigan. Turning the tide will take ongoing action and collaboration among the healthcare community, payers, government, and a multitude of other sectors. During this one-day conference hosted by Family Medicine Foundation of Michigan in partnership with Michigan Department of Licensing and Regulatory Affairs and Priority Health, , opioid prescribers will get the most up-to-date information on national, state, and community efforts underway; rules and guidelines that healthcare professionals must follow; and the tools that are available to assist them.
Target Audience: Practicing Physicians and their staff, Family Medicine Residents, Medical Students, and all professionals impacted by the opioid epidemic.
(Subject to change)
Welcome & Introductions
James Forshee, MD, Senior Vice President and Chief Medical Officer, Priority Health (Grand Rapids)
Keynote: Steps for Action: Impacting the Rapidly Changing Landscape of the Opioid Crisis
Taking action to address the opioid crisis first requires foundational knowledge of its root causes. During this session you will develop an understanding of the pathophysiology and neurological basis of addiction and the role of prescription opioids, heroin, and synthetic opioid analogues. You will also learn what’s being done at the state level to combat the crisis, and what you, as a healthcare professional, can do to minimize risk for Opioid Use Disorder, overdose, and death.
David R. Neff, DO, Chief Medical Director, Office of Medical Affairs, Medical Services Administration, Michigan Department of Health and Human Services (Lansing)
Effectively and Safely Managing Pain: CDC Guideline for Prescribing Opioids
Effectively and safely managing pain requires much more than writing a prescription. Gain insight on the 12 recommendations of the CDC Guideline for Prescribing Opioids for Chronic Pain, which offer different approaches for ensuring patients have access to safer, more effective chronic pain treatment while reducing the number of people who misuse, abuse, or overdose from these drugs.
Amber Daniels, MA, Training and Education Coordinator, Michigan Department of Health and Human Services (Lansing)
Launched in April 2017, the state’s new Michigan Automated Prescription System (MAPS) is improving how prescribers and dispensers assess patient risk for drug misuse, abuse, and overdose. Learn about the latest MAPS updates, including a new prescriber mandate and associated sanctions that were signed into state law in December 2017, as well as the complaint process.
Kim Gaedeke, BS, Public Policy, Acting Deputy Director, Michigan Department of Licensing and Regulatory Affairs (Lansing)
11:17 a.m.-12 p.m.
Boots on the Ground: Opioid Management in High Utilization Areas
Gather tips, tricks, and tools to turn THEORY into PRACTICE for pain management in outpatient primary care. Learn effective approaches for patient education; how to implement and utilize physician-patient contracts, Uniform Data System, and MAPS; and how to approach tapering as a method for discontinuing pain medication while maintaining your physician-patient relationships.
Harshini Jayasuriya, MD, Medical Director and Professor, Michigan Volunteers of America PACE, Senior Community Center (Lansing)
Medicaid Coordinated Drug Review Board
The Drug Utilization Review (DUR) board—federally mandated for each state Medicaid program—oversees and monitors prescribing patterns for Medicaid beneficiaries to identify risk and best practices. Learn how Michigan’s DUR board is changing narcotic prescribing for the state’s Medicaid population to help impact the effects of the opioid crisis in our state.
Catherine Reid, MD, Consulting Physician, Office of Medical Affairs, Medical Services Administration, Michigan Department of Health and Human Services (Lansing)
Priority Health Opioid Initiatives
In effort to help our members get healthy and stay healthy, Priority Health launched an opioid management strategy. Our goal is to reduce our members’ opioid use by 25 percent over three years. The four pillars of our campaign work in concert to remove opioids from circulation, decrease the number of opioids prescribed, increase the availability of rescue medicines, and improve and promote access to care management and behavioral health services.
Christina Barrington, PharmD, Vice President of Pharmacy Programs, Priority Health (Grand Rapids)
The Role of Acute Care Prescribing in the Opioid Epidemic
Excess prescribing after surgery often leads to unused pills becoming a source for diversion and abuse. Learn how the Michigan Opioid Prescribing Engagement Network (MI-OPEN) is addressing acute care prescribing as a preventive model for the opioid epidemic.
Calista Harbaugh, MD, Research Fellow, Michigan OPEN; General Surgery Resident, University of Michigan (Ann Arbor)
DEA: Your Partner in Combating Opioid Misuse, Abuse, and Overdose
With the mission to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate needs, the Drug Enforcement Administration’s Diversion Control Division is a key partner in addressing the opioid epidemic. Hear directly from the DEA about legal and regulatory requirements for healthcare professionals handling controlled substances, federal prescription requirements, state dispensing data, egregious activity, and more. Come with your questions as there will be time for an interactive Q&A.
Cathy Gallagher, BS, Diversion Program Manager, Drug Enforcement Administration (Detroit)
Movement Toward a Safer Population
Together we will complete the day by exploring the epidemiology of opioid use through a historical context followed by a discussion of treatment opportunities appropriate for a Family Medicine practice.
Cara Poland, MD, MEd, FACP, FASAM, Physician, Spectrum Health and Michigan State University (Grand Rapids)
Closing Remarks & Next Steps
Tricia Baird, MD, FAAFP, Medical Director, Priority Health (Grand Rapids)
Click here to print the agenda for both SE MI (03/23/18) and West MI (04/20/18).
Click here to access a hard copy registration form that may be either faxed or scanned/emailed.
Click here to access a LARA CME Requirements Brochure. This conference meets state mandated Pain & Symptom Management professional development requirements.
Click here to access the speakers' presentations and T2P forms (password required).
Schedule is subject to change.
Early-bird pricing ends 04/09/2018
Online registration ends 04/18/2018
Family Medicine Foundation of Michigan
MAPS & More West MI: Update for Opioid Prescribers
SOLD OUT as of April 11
Contact Denise Cook if you would like to be placed on a waitlist (in case of any cancellation).
Friday, April 20, 2018
8:30 a.m.-4:30 p.m.
Frederik Meijer Gardens
1000 E. Beltline Ave. NE
Grand Rapids, MI 49525
8:30 a.m.-4:30 p.m.
Continental breakfast & lunch are included
Members must log in with their AAFP ID# and password to access member rates for themselves and their support staff.
Early-bird rates through April 9, 2018
MAFP Physician Member: $149
MAFP Physician Members' Staff: $149
MAFP Life Member: $149
MAFP Resident Member: $99
MAFP Student Member: $99
Non-MAFP Member: $199
Speakers' Presentation Materials: Approximately 7-10 days prior to the conference, registrants will be sent a Know Before You Go email that will include a password to access speakers' presentations.
This Live activity, MAPS & More: Update for Opioid Prescribers, from 03/23/2018 - 12/31/2018, has been reviewed and is acceptable for up to 7.00 Prescribed credit(s) without t2p exercises and up to 11.00 Prescribed credits with t2p exercises by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Following this CME activity, participants will have the opportunity to earn an additional two Prescribed credits for participation in each Translation to Practice® (t2p™) exercise. There will be two sessions associated with this added opportunity. Information on Translation to Practice® will be shared within the activity.